GlassScriptPhysician profile
Matthew Thomas Marshall
NPI 1346685195
$853.16
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $193 · 2021: $60.04 · 2022: $14.41 · 2023: $128 · 2024: $81.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $209.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Geistlich Pharma, North America, INC. | $276.85 | 2019 | |
| Depuy Synthes Sales INC. | $204.69 | 2020-2024 | Trumatch |
| Stryker Corporation | $128.43 | 2023 | Vsp System, Vsp Cranial |
| Straumann USA LLC | $99.27 | 2019-2020 | |
| Nobel Biocare USA | $74.45 | 2021-2022 | |
| Axogen | $69.47 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.